Citation Tools
PDFLate-breaking abstracts
Novel single-agent immunotherapies
861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells